Netherlands Healthcare Regulatory and Reimbursement Market Research Report: Ken Research

0


GlobalData, the industry analysis specialist, has released its latest report, “Country Focus: Healthcare Regulatory and Reimbursement Landscape-The Netherlands“. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in the Netherlands. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData ‘steam of industry experts.

The value of the pharmaceuticals market decreased from USD 7.1 billion in 2009 to USD 5.3 billion in 2016 at a negative Compound Annual Growth Rate (CAGR) of 4%, and this value is expected to decrease further from USD 5.1 billion in 2017 to USD 4.3 billion in 2021 at a negative CAGR of 4%. The medical device market was worth USD 3.5 billion in 2016 and is projected to reach USD 4.3 billion by 2021 at a CAGR of 4%.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in the Netherlands, and includes an overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers Profiles and SWOT analyses of the major players in the pharmaceutical market: Teva, Pfizer, Merck, Roche, and AbbVie; and of major players in the medical device market: Medtronic, Essilor, Roche, Zimmer Biomet, and Ethicon An insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country ‘shealthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices Detailed analysis of the country’ shealthcare environment, demographics, healthcare infrastructure and healthcare expenditure An overview of the opportunities for and challenges to growth in the Netherlands’ healthcare market

Key Topics Covered in the Report:

Netherlands Healthcare Regulatory and Reimbursement Research Report

Netherlands Healthcare Regulatory Market Trends

Netherlands Healthcare Regulatory and Reimbursement Market Growth

Netherlands Healthcare Reimbursement Market Demand

Netherlands Healthcare Regulatory Market Size

Healthcare Regulatory and Reimbursement in Netherlands

Netherlands Healthcare Regulatory and Reimbursement Market Share

Netherlands Healthcare Regulatory and Reimbursement Market Analysis

Netherlands Healthcare Reimbursement Industry Research

Netherlands Healthcare Regulatory and Reimbursement Market Revenue

To know more, click on the link below:

https://www.kenresearch.com/healthcare/pharmaceuticals/countryfocus-healthcare-regulatory-and-reimbursement/142635-91.html

Related reports

https://www.kenresearch.com/healthcare/pharmaceuticals/countryfocus-healthcare-regulatory-reimbursement-landscape-canada/136387-91.html

https://www.kenresearch.com/healthcare/general-healthcare/healthcare-mgr-2017/134594-91.html

Contact:

Ken Research

Ankur Gupta, Head Marketing & Communications

sales@kenresearch.com

+91-124-4230204

Share.

Comments are closed.